Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20126955 | 0.85 | ALDH1A1 (0.32) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL26017171 | 0.82 | PTGS1 (0.33) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL18875993 | 0.78 | MAPT (0.33) | ALDH1A1KDM4E | |
| SCHEMBL25146224 | 0.74 | CA2 (0.34) | CA2PTGS1PTGS2ALOX5ADORA2A | |
| SCHEMBL20146546 | 0.73 | ADORA2A (0.33) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL22813264 | 0.71 | ALDH1A1 (0.31) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL203914 | 0.70 | DYRK1A (0.34) | ALDH1A1KDM4EADORA2AADORA1 | |
| SCHEMBL14282450 | 0.70 | MAPT (0.33) | ALDH1A1KDM4E | |
| SCHEMBL26014312 | 0.68 | NEK1 (0.32) | CA2PTGS1PTGS2NEK1 | |
| SCHEMBL18775167 | 0.66 | MAPT (0.33) | ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180130956-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-10 | — | — | US | disclosed |
| US-20180130956-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180130956-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | CYCS, OXA1L, ICOSLG | ALDH1A1 3112/4885CA2 2259/4885POLB 1409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.